ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 161 filers reported holding ANIKA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $273 | -99.9% | 8,784 | -22.4% | 0.00% | 0.0% |
Q3 2022 | $287,000 | +0.7% | 11,314 | -9.3% | 0.00% | 0.0% |
Q2 2022 | $285,000 | -2.7% | 12,479 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $293,000 | -24.5% | 12,479 | +3.7% | 0.00% | -33.3% |
Q4 2021 | $388,000 | -30.0% | 12,029 | -8.6% | 0.00% | 0.0% |
Q3 2021 | $554,000 | -0.7% | 13,165 | -2.3% | 0.00% | 0.0% |
Q2 2021 | $558,000 | -7.2% | 13,480 | -6.9% | 0.00% | -25.0% |
Q1 2021 | $601,000 | +2.9% | 14,478 | -3.4% | 0.00% | 0.0% |
Q4 2020 | $584,000 | +11.5% | 14,983 | +0.8% | 0.00% | 0.0% |
Q3 2020 | $524,000 | -4.2% | 14,869 | -1.2% | 0.00% | 0.0% |
Q2 2020 | $547,000 | +18.7% | 15,043 | +9.1% | 0.00% | 0.0% |
Q1 2020 | $461,000 | -19.8% | 13,793 | +3.0% | 0.00% | 0.0% |
Q4 2019 | $575,000 | -18.0% | 13,392 | +3.6% | 0.00% | -33.3% |
Q3 2019 | $701,000 | +30.3% | 12,923 | -1.9% | 0.01% | +50.0% |
Q2 2019 | $538,000 | +20.4% | 13,168 | -6.5% | 0.00% | 0.0% |
Q1 2019 | $447,000 | -12.9% | 14,079 | +1.5% | 0.00% | 0.0% |
Q4 2018 | $513,000 | -10.5% | 13,871 | -1.9% | 0.00% | -20.0% |
Q3 2018 | $573,000 | +6.3% | 14,144 | -8.7% | 0.01% | +25.0% |
Q2 2018 | $539,000 | -24.2% | 15,492 | -0.8% | 0.00% | -20.0% |
Q1 2018 | $711,000 | -24.1% | 15,621 | +2.5% | 0.01% | -16.7% |
Q4 2017 | $937,000 | +9.1% | 15,246 | -4.0% | 0.01% | 0.0% |
Q3 2017 | $859,000 | +15.9% | 15,876 | +1.5% | 0.01% | 0.0% |
Q2 2017 | $741,000 | -2.0% | 15,649 | -5.3% | 0.01% | 0.0% |
Q1 2017 | $756,000 | -4.5% | 16,519 | +4.3% | 0.01% | 0.0% |
Q4 2016 | $792,000 | +9.5% | 15,834 | +4.9% | 0.01% | 0.0% |
Q3 2016 | $723,000 | +3.9% | 15,095 | +4.3% | 0.01% | 0.0% |
Q2 2016 | $696,000 | -2.8% | 14,479 | -2.1% | 0.01% | 0.0% |
Q1 2016 | $716,000 | +31.6% | 14,792 | +0.1% | 0.01% | +20.0% |
Q4 2015 | $544,000 | +15.0% | 14,779 | -0.5% | 0.01% | +25.0% |
Q3 2015 | $473,000 | -51.3% | 14,858 | -49.5% | 0.00% | 0.0% |
Q2 2015 | $972,000 | +61.5% | 29,414 | +101.2% | 0.00% | -20.0% |
Q1 2015 | $602,000 | -47.4% | 14,619 | -48.0% | 0.01% | 0.0% |
Q4 2014 | $1,144,000 | +119.2% | 28,096 | +97.2% | 0.01% | 0.0% |
Q3 2014 | $522,000 | -2.4% | 14,244 | +23.3% | 0.01% | 0.0% |
Q2 2014 | $535,000 | +14.3% | 11,550 | +1.5% | 0.01% | +25.0% |
Q1 2014 | $468,000 | +3.1% | 11,377 | -4.3% | 0.00% | 0.0% |
Q4 2013 | $454,000 | – | 11,890 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |